Home  > 
  Karnataka govt woos scientists and entrepreneurs to set up nano tech ventures in the state,   December 12, 2017
  Alembic's associated company Rhizen Pharma gets US FDA fast track status for tenalisib to treat PTCL,   December 11, 2017
  EMA accepts USV’s marketing authorization application for proposed biosimilar Pegfilgrastim,   December 07, 2017
  Claris Lifesciences Board approves delisting proposal,   December 07, 2017
  GSK phase III study supports safety & efficacy of Shingrix in preventing shingles in auHSCT patients,   December 07, 2017
  Shilpa Medicare gets 10 observations from US FDA for Jadcheria formulation facility,   December 06, 2017
  Indian healthcare market likely to touch $372 bn by 2022 with CAGR of 22%: Assocham-RNCOS study,   December 04, 2017
  Biocon, Mylan get US FDA nod for Ogivri, biosimilar for trastuzumab for HER2-positive breast & gastric cancers,   December 04, 2017
  India’s top 20% pharmaceutical workforce is on par with global standards: Uma Nandan Misra,   December 02, 2017
  Vimta Labs net profit zooms by 99% in Q2, scrip moves up by 20%,   December 01, 2017
  Vimta Labs net profit zooms by 99% in Q2, scrip moves up by 20%,   December 01, 2017
  Glenmark closes decentralised registration procedure for generic Seretide Accuhaler in Nordic region,   December 01, 2017
  Dr. Reddy’s gets US FDA approval for Impoyz cream, 0.025%,   December 01, 2017
  Piramal Enterprises acquires Digeplex and associated brands from Shreya Lifesciences,   November 30, 2017
  Income tax officers raid pharma distributors, healthcare centres and path labs suspecting non-disclosure of accounts,   November 30, 2017
  Himalaya Drug Company introduces novel oral rinse ‘Oro-T’ for cancer patients,   November 30, 2017
  Cipla launches Q-TIB globally for T.B. prophylaxis in HIV,   November 30, 2017
  Mylan launches biosimilar Bevacizumab as ABEVMY in India for variety of cancers,   November 29, 2017
  Shalby Ltd entering capital market with IPO of 10 lakh shares with price band of Rs.245 to 248,   November 29, 2017
  Glenmark Pharma's Baddi unit gets 7 observations from US FDA,   November 28, 2017

Pre-Connect Congress 2017
Copyright © 2016 Saffron Media Pvt. Ltd |